Search

中文 / English

Copyright: Shenzhen Kangtai biological products Limited by Share Ltd   Address: No. 6, KORUN Road, Nanshan District science and Technology Park, Shenzhen Tel:86-755-26988688
粤ICP备06026377号   Fax:86-755-26988600         E-mail:office@biokangtai.com        Hotline:400-880-6992    Powered by www.300.cn

>
>
>
BioKangtai’ s COVID-19 Inactivated Vaccine Received Approval for Clinical Trial

BioKangtai’ s COVID-19 Inactivated Vaccine Received Approval for Clinical Trial

Release time:
2020/10/27
Page view

On September 28, the COVID-19 inactivated vaccine (Vero cell) independently developed by BioKangtai has been approved by the National Medical Products Administration for clinical trial. It has become the first novel coronavirus vaccine to enter clinical trial in Guangdong Province.

The first phase of the COVID-19 inactivated vaccine production workshop has been completed. It is expected to have an annual production capacity of 100 million doses/year by the end of this year.